ENvue Medical (FEED) EBT Margin (2014 - 2026)
ENvue Medical's (FEED) quarterly EBT Margin came in at 580.25% in Q1 2026, down 39907.0% year-on-year from N/an in Q1 2025, and up 86.36% on a QoQ basis from 4253.53% in Q4 2025.
ENvue Medical (FEED) EBT Margin (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has 13 years of EBT Margin data on file, last reported at 580.25% in Q1 2026.
- On a quarterly basis, EBT Margin fell 39907.0% year-over-year to 580.25% in Q1 2026; TTM through Mar 2026 was 936.45%, a 88517.0% decrease from a year earlier, with the FY2025 full-year figure at 724.32%, down 72085.0% from the prior year.
- EBT Margin for Q1 2026 stood at 580.25%, up from 4253.53% in the prior quarter.
- Over the last five years, EBT Margin for FEED reached as high as 2021.57% in Q4 2022 and fell as low as 4253.53% in Q4 2025.
- Historically, EBT Margin has averaged 363.29% across 5 years, with a median of 264.63% in 2024.
- Across the five-year window, EBT Margin soared 433980 bps in 2022 and plunged 474249 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 2021.57% in 2022, then sank by 103 bps to 68.14% in 2023, then soared by 818 bps to 488.96% in 2024, then sank by 970 bps to 4253.53% in 2025, then jumped by 86 bps to 580.25% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 580.25% in Q1 2026, 4253.53% in Q4 2025, and 75.48% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 22.61% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 9.84% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 4.87% |
| 10 | ENvue Medical | 1.18 Mn | -1.09 Mn | -55,000.00 | -580.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -580.25% |
| Dec 31, 2025 | -4,253.53% |
| Sep 30, 2025 | 75.48% |
| Jun 30, 2025 | -791.30% |
| Mar 31, 2025 | -181.17% |
| Dec 31, 2024 | 488.96% |
| Sep 30, 2024 | -264.63% |
| Jun 30, 2024 | -83.72% |
| Mar 31, 2024 | -63.08% |
| Dec 31, 2023 | -68.14% |
| Sep 30, 2023 | -158.08% |
| Jun 30, 2023 | -360.88% |
| Mar 31, 2023 | -309.32% |
| Dec 31, 2022 | 2,021.57% |
| Sep 30, 2022 | -969.07% |
| Jun 30, 2022 | -265.15% |
| Mar 31, 2022 | -413.60% |
| Dec 31, 2021 | 3,361.81% |
| Sep 30, 2021 | -1,323.65% |
| Jun 30, 2021 | -69.18% |